Discounted Cash Flow (DCF) Analysis Levered
Clover Health Investments, Corp. (CLOV)
$0.8454
-0.04 (-4.30%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 462.27 | - | - | - | - | - | - | - | - |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | |||||||||
| Operating Cash Flow | -159.88 | - | - | - | - | - | - | - | - |
| Operating Cash Flow (%) | |||||||||
| Capital Expenditure | -0.02 | - | - | - | - | - | - | - | - |
| Capital Expenditure (%) | |||||||||
| Free Cash Flow | -159.90 | - | - | - | - | - | - | - | - |
Weighted Average Cost Of Capital
| Share price | $ 0.8,454 |
|---|---|
| Beta | 2.103 |
| Diluted Shares Outstanding | 476.24 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 23.26% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 13.453 |
| Total Debt | 5.86 |
| Total Equity | 402.62 |
| Total Capital | 408.48 |
| Debt Weighting | 1.43 |
| Equity Weighting | 98.57 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 462.27 | - | - | - | - | - | - | - | - |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -159.88 | - | - | - | - | - | - | - | - |
| Capital Expenditure | -0.02 | - | - | - | - | - | - | - | - |
| Free Cash Flow | -159.90 | - | - | - | - | - | - | - | - |
| WACC | |||||||||
| PV LFCF | - | - | - | - | - | - | - | - | |
| SUM PV LFCF | - |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 13.59 |
| Free cash flow (t + 1) | - |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | -97.93 |
| Equity Value | - |
| Shares Outstanding | 476.24 |
| Equity Value Per Share | - |